IP Case Law › Patents › Monsanto Technology LLC & Ors. v. Nuziveedu Seeds Ltd. & Ors…
Relevant Acts and provisions
Code of Civil Procedure, 1908
Patents Act, 1970
Provisions considered: Section 3(j) and Section 64 of the Patents Act, 1970, read with Order XXXIX of the Code of Civil Procedure, 1908.
Brief facts
Monsanto licensed its patented Bt cotton technology to Nuziveedu Seeds under a sub-licence providing for trait fees. After Monsanto terminated the agreement over a trait-fee dispute, it sued Nuziveedu for patent infringement and sought an interim injunction. Nuziveedu counter-claimed for revocation, contending the patent was barred by Section 3(j) as a biological process. The Single Judge granted a limited interim injunction without deciding patentability, but the Division Bench itself examined and upheld the Section 3(j) objection, effectively allowing the revocation counter-claim summarily.
Issues before the Court
- Could the Division Bench, in an appeal against an interim injunction, summarily decide the exclusion under Section 3(j) and allow the revocation counter-claim without a trial?
- Was the interim arrangement granted by the Single Judge an appropriate exercise of discretion?
Court's findings
The Court held that Section 64 of the Patents Act, which permits revocation on a counter-claim in a suit, presupposes consideration of the claims in accordance with law, following the procedure prescribed by the Code of Civil Procedure for framing issues and taking evidence, and not summary adjudication without trial. The Court held that whether the plaintiffs' DNA construct and Bt trait technology fell within the exclusion in Section 3(j) involved complicated mixed questions of law and fact concerning biotechnology that required expert evidence.
The Court observed that the defendants had themselves argued before the Division Bench that these issues were too complex to be decided without a full trial, making it inconsistent for the same issues then to be decided summarily in their favour.
The Court held that the Division Bench ought to have confined itself to reviewing the correctness of the interim injunction and, finding the Single Judge's arrangement just, set aside the Division Bench's order and remanded the suit for full trial.
Decision
Division Bench order set aside; the Single Judge's interim order restored; suit and revocation counter-claim remanded for disposal after a full trial.
Key legal principle / ratio
Revocation of a patent on a counter-claim under Section 64 of the Patents Act, 1970 cannot be decided summarily; it presupposes a full trial in accordance with the Code of Civil Procedure, particularly where patent exclusion under Section 3(j) turns on complex mixed questions of law and fact requiring expert evidence. An appellate court reviewing an interlocutory injunction should confine itself to the propriety of that order and not finally adjudicate the validity of the patent.
Keywords
Biotechnology Patent Counter-claim Interim Injunction Patent Eligibility Section 3(j) Summary Adjudication
Read the judgment
More Patents judgments
Array Biopharma Inc v. Deputy Controller of Patents and Designs
A combination of distinct and independent active drugs, each with its own chemical identity and mechanism, does not fall under the Section 3(d) bar for derivatives of known substances. Using phrases such as 'for simultaneous, sepa…
Inventive StepMethod of TreatmentPharmaceutical CombinationPrior ArtPatentsBayer Corporation v. Union of India & Ors.
A compulsory licence under Section 84 of the Patents Act, 1970 may be granted where the reasonable requirements of the public with respect to a patented invention have not been satisfied, the invention is not available at a reason…
Compulsory LicencePublic HealthReasonably Affordable PriceSection 84PatentsBigtec Private Limited v. Assistant Controller of Patents and Designs
An objection that devising nucleotide probes or primers is routine experimentation lacking inventive step under Section 2(1)(ja) must engage with evidence of unexpected effects placed on record; and the Section 3(c) exclusion for …
BiotechnologyInventive StepPatent ProsecutionPrior Art